Search

Now showing items 1-4 of 4

Maternal serum advanced glycation end products level as an early marker for predicting preterm labor/PPROM: a prospective preliminary study

Kansu Çelik, Hatice; Taşçı, Yasemin; Kısa Karakaya, Burcu; Çınar, Mehmet; Çandar, Tuba; Çağlar, Gamze Sinem (2018-03-22)

Objective: To evaluate the value of maternal serum advanced glycation end products (AGEs) level at 11–13 weeks’ gestation for the prediction of preterm labor and or preterm premature rupture of membranes (PPROM). Materials ...

Importance of hba1c and fructosamine as a marker of glycemic control and evaluation of some biochemical parameters during pregnancy

Şeker, Rabia; Özdemir, Elif Didem; Çağlar, Gamze Sinem; Demirtaş, Selda (2014)

Amaç: Diyabetin kontrol ve monitorizasyonu fetal malformasyon, makrozomi ve diğer komplikasyonlar nedeniyle gebelikte özellikle önemlidir. Çalışmamız, monitorizasyonda en sık kullanılan iki parametre olan hemoglobin A1c ...

Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance

Çağlar, Gamze Sinem; Öztaş, Efser; Karadağ, Demet; Pabuçcu, Recai; Demirtaş, Selda (Elsevier Science Inc, 2011)

The aim of this study was to evaluate ischemia-modified albumin levels (IMA) in polycystic ovary syndrome (PCOS) cases with and without insulin resistance and the correlation of IMA with carotid intima media thickness, ...

Association of anti-Mullerian hormone and small-dense low-density lipoprotein cholesterol with hepatosteatosis in young lean women with and without polycystic ovary syndrome

Öztaş, Efser; Çağlar, Gamze Sinem; Kaya, Cemil; Karadağ, Demet; Demirtaş, Selda; Kurt, Mevlüt; Pabuçcu, Recai (Elsevier Science Bv, 2014)

Objective: To study the association of anti-Mullerian hormone (AMH) and small-dense low-density lipoprotein cholesterol (sd-LDL) with hepatosteatosis among young, lean, polycystic ovary patients. Study design: A prospective, ...